rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2004-1-30
|
pubmed:abstractText |
Improvement in outcome of childhood high-risk (HR) ALL was sought with a very intensive Nordic protocol leaving most patients without CNS-RT.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1545-5009
|
pubmed:author |
pubmed-author:CarlsenNN,
pubmed-author:FlaegstadTT,
pubmed-author:ForestierEE,
pubmed-author:GlomsteinAA,
pubmed-author:GustafssonGG,
pubmed-author:KristinssonJJ,
pubmed-author:LanningMM,
pubmed-author:MellanderLL,
pubmed-author:Nordic Society of Pediatric Hematology and Oncology,
pubmed-author:Saarinen-PihkalaUlla MUM,
pubmed-author:SchroederHH
|
pubmed:copyrightInfo |
Copyright 2003 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8-23
|
pubmed:dateRevised |
2009-1-12
|
pubmed:meshHeading |
pubmed-meshheading:14752789-Adolescent,
pubmed-meshheading:14752789-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14752789-Central Nervous System Neoplasms,
pubmed-meshheading:14752789-Child,
pubmed-meshheading:14752789-Child, Preschool,
pubmed-meshheading:14752789-Cohort Studies,
pubmed-meshheading:14752789-Combined Modality Therapy,
pubmed-meshheading:14752789-Cranial Irradiation,
pubmed-meshheading:14752789-Cytarabine,
pubmed-meshheading:14752789-Disease-Free Survival,
pubmed-meshheading:14752789-Female,
pubmed-meshheading:14752789-Humans,
pubmed-meshheading:14752789-Infant,
pubmed-meshheading:14752789-Male,
pubmed-meshheading:14752789-Methotrexate,
pubmed-meshheading:14752789-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:14752789-Risk Factors,
pubmed-meshheading:14752789-Stem Cell Transplantation,
pubmed-meshheading:14752789-Transplantation, Homologous,
pubmed-meshheading:14752789-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation.
|
pubmed:affiliation |
Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland. ulla.pihkala@hus.fi
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|